ASML: Why I'm Not Buying Here

ASML’s Q1 revenue and net income beat expectations, with operating leverage and tighter expense control driving margin expansion. The company also lifted 2026 revenue guidance to €36–40 billion, but the outlook is tempered by export control risks and uncertainty around H2 growth and bookings. The stock is rated Hold with a $1,291 target, implying valuation downside despite strong AI-driven demand.

Analysis

ASML is in the awkward zone where fundamentals are better than the stock’s ability to re-rate. The market is still paying for a monopoly-ish tool franchise, but export controls cap the addressable upside because every incremental AI capex dollar is not fully monetizable into shipments. That creates a lagged earnings-risk setup: near-term margins can keep surprising, while the equity can still de-rate if bookings fail to confirm the 2026 setup.

The real second-order effect is on the semi supply chain. If ASML’s order visibility softens, wafer-fab equipment peers with more cyclical exposure should feel it first, but chipmakers with aggressive AI roadmaps also get a hidden benefit from equipment scarcity because constrained capacity preserves pricing power for leading-node logic and HBM ecosystems. In other words, weaker ASML order momentum is not automatically bearish for AI semis; it can actually reinforce scarcity economics for the highest-end foundry and memory names.

The risk/catalyst balance is asymmetric over the next 1-2 quarters. The upside catalyst is any evidence that bookings are not just delayed but accelerating into a stronger 2026 demand slope; the downside catalyst is a single export-control escalation or a weaker-than-expected order intake print that forces the market to haircut the 2026 guide. Consensus appears to be underpricing how quickly a premium multiple can compress when a capital goods monopoly loses narrative momentum, even if earnings remain fine.

Contrarian takeaway: the stock may not be expensive because of current earnings, but because the market is already discounting a clean AI monetization path that policy can interrupt. That makes the setup more about timing than direction—fundamentals may stay strong for months while the multiple bleeds. The better trade may be relative value versus other AI infrastructure names that are less exposed to export-license volatility.

Key Decisions for Investors

• Short ASML into strength on any post-earnings rally, using a 1-3 month horizon; the risk/reward favors a multiple compression trade if bookings do not re-accelerate, with downside driven by guidance skepticism rather than earnings misses.
• Pair trade: long best-in-class AI demand beneficiaries with less policy risk (e.g., NVDA or TSM) vs short ASML for 2-4 months; this isolates AI capex exposure while hedging broad semis beta and monetizes the export-control discount.
• Buy ASML downside protection via 3-6 month put spreads if implied vol is below realized; the clean catalyst is a bookings disappointment or sanctions headline that can reprice the stock faster than fundamentals deteriorate.
• Avoid chasing long exposure in semiconductor equipment until order visibility improves; wait for a pullback or a confirmed order inflection, since the 2026 guide is only credible if H2 bookings hold up.